CAS 1640972-35-5
:Tofacitinib Related Compound 21
CAS:Formel:C16H22N6OFarbe und Form:Pale Yellow SolidMolekulargewicht:314.395,6-Dihydro Tofacitinib
CAS:Kontrolliertes ProduktApplications 5,6-Dihydro CP-690550 is an impurity of CP-690550 (C781350), a pyrrolo[2,3-d]pyrimidine derivative, as Janus kinase inhibitor for treatment of rheumatoid arthritis.
References Sheiner, L., et al.: Clin. Pharmacol. Ther., 25, 358 (1979); Dayneka, N., et al.: J. Pharmacokin. Biopharm., 21, 457 (1993); Changelian, P., et al.: Science, 302, 875 (2003); Lee, H., et al.: Clin. Pharmacol. Ther., 73, 348 (2003); Hutmacher, M., et al.: J. Clin. Pharmacol., 47, 238 (2007)Formel:C16H22N6OFarbe und Form:NeatMolekulargewicht:314.39Tofacitinib impurity
CAS:Tofacitinib impurity is a pharmacopoeia grade synthetic tofacitinib impurity intended for the manufacture of drug products and research and development. It is a custom synthesis that is not found in nature. Tofacitinib impurity is used for the production of analytical standards and as an impurity standard for HPLC analysis. The purity of this product is greater than 99% with a specific gravity between 1.2-1.3 g/mL at 25°C, an assay range between 20-200 μg/mL, and a melting point range between 124-128°C.Reinheit:Min. 95%Molekulargewicht:314.39 g/molTofacitinib dihydro impurity
CAS:Tofacitinib dihydro impurity is a research and development impurity standard for the synthesis of Tofacitinib. It is a custom synthesis with high purity, pharmacopoeia grade, and synthetic. This product is also used in drug development for metabolism studies and analytical applications.
Formel:C16H22N6OReinheit:Min. 95%Molekulargewicht:314.39 g/mol
